Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ B7-H4 Recombinant Rabbit Monoclonal Antibody (BLR043F)
Rabbit Recombinant Monoclonal Antibody
$173.10 - $523.50
Specifications
Antigen | B7-H4 |
---|---|
Clone | BLR043F |
Concentration | 50 μg/mL |
Content And Storage | 4°C |
Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot, Immunocytochemistry |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
PIMA544281
|
Invitrogen™
MA544281 |
100 μL |
Each for $523.50
|
|
|||||
PIMA544282
|
Invitrogen™
MA544282 |
10 μL |
Each for $173.10
|
|
|||||
Description
Epitope retrieval with citrate buffer pH6.0 is recommended for FFPE cell sections.
B7-H4 (B7x, VTCN1) a costimulatory protein which is reported to function as a negative regulator of T-cell mediated immunity. Although B7-H4 binds an unknown receptor, it is thought to deliver an inhibitory signal to T-cells preventing their proliferation, cell cycle progression and interleukin-2 production. B7-H4 deficient mice are only minimally affected; suggesting B7-H4 is important in the fine tuning of the T-cell mediated immune response. B7-H4 is expressed on activated T-cells, B-cells, monocytes and dendritic cells. Aberrant expression has been associated with cancers of the lung, breast and ovary in humans. B7-H4 is expressed primarily on the membrane of lymphoid cells, and as an immunoinhibitory protein that interacts with receptors on the surface of T lymphocytes, it is involved in mediating cellular and humoral immune responses. Overexpression of B7-H4 is associated with certain malignancies, including ovarian and breast cancer, which may be a mechanism by which tumor cells suppress T cell immunity and facilitate tumor progression. Further, VTCN1 may be a useful biomarker for the early detection of ovarian cancer and Renal Cell Carcinoma (RCC).Specifications
B7-H4 | |
50 μg/mL | |
Flow Cytometry, Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot, Immunocytochemistry | |
Unconjugated | |
Rabbit | |
RUO | |
BBS with 0.1% BSA and 0.09% sodium azide; pH 7.8-8.6 | |
Q7Z7D3 | |
79679 | |
Recombinant protein representing the extracellular domain of human B7-H4 (residues 30-282). | |
Antibody |
BLR043F | |
4°C | |
Recombinant Monoclonal | |
Liquid | |
IgG | |
Human | |
Vtcn1 | |
B7 family member, H4; B7 homolog 4; B7 superfamily member 1; B7h.5; B7H4; B7-H4; B7s1; B7x; BC032925; EMBL:AAH95842.1}; FLJ22418; immune costimulatory protein B7-H4; PRO1291; Protein B7S1; RGD1311204; RP11-229A19.4; t cell costimulatory molecule B7x; T-cell costimulatory molecule B7x; UNQ659/PRO1291; VCTN1; V-set domain containing T cell activation inhibitor 1; V-set domain containing T-cell activation inhibitor 1; V-set domain-containing T-cell activation inhibitor 1; Vtcn1; vtcn1 {ECO:0000312 | |
Vtcn1 | |
Primary | |
Purified |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title